Navigation Links
NutraCea to Host First Quarter 2008 Conference Call on May 12.
Date:5/8/2008

PHOENIX, May 8 /PRNewswire-FirstCall/ -- NutraCea (OTC Bulletin Board: NTRZ), a world leader in stabilized rice bran (SRB), nutrient research and technology, announced today that it will release its first quarter financial results on Monday, May 12 after the market closes.

Management will host the conference call at 7:00pm ET on Monday, May 12th to review the first quarter financial results for 2008 and provide management updates. Parties interested in listening to the conference call should call 800-257-1927. International callers should dial 303-262-2138.

The call is also available via a webcast that can be accessed at http://www.investorcalendar.com/IC/CEPage.asp?ID=129642 and will be archived for 30 days.

About NutraCea

NutraCea is a leader in stabilized rice bran nutrient research and dietary supplement development. Through its wholly owned subsidiary RiceX, the company manufactures as well as distributes products and food ingredients made from Rice Bran through its proprietary technology and processes. The Company has developed intellectual properties to create a range of proprietary product formulations, delivery systems and whole food nutrition products. NutraCea's proprietary technology enables the creation of food and nutrition products from rice bran, normally a wasted by-product of standard rice processing. In addition to its whole foods products, NutraCea develops families of health-promoting "nutraceuticals," including natural arthritic relief and cholesterol-lowering products. More information can be found in the company's filings with the SEC and you can visit the NutraCea web site http://www.NutraCea.com.

Investor Relations Contact:

Marilynn Meek

Financial Relations Board

212-827-3773

mmeek@frbir.com <
'/>"/>

SOURCE NutraCea
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. NutraCea Appoints Financial Relations Board as New Investor Relations Firm
2. NutraCea to Host Third Quarter 2007 Financial Results Conference Call November 14
3. NutraCea Announces Conference Call to Report Second Quarter Financial Results
4. NutraCea Forms Joint Ventures With HerbalScience to Develop Nutraceutical Extracts and Pharmaceutical Chemistries From Stabilized Rice Bran
5. NutraCea Provides Update on Domestic Operations
6. NutraCea Files Universal Shelf Registration Statement
7. NutraCea to Purchase Largest Rice Bran Oil Processing Facility in South America
8. New World Record Holder in Powerlifting Credits NutraCeas Unique Rice-Bran-derived Product as his Secret Weapon
9. NutraCea Appoints New Chief Financial Officer
10. NutraCea-Sponsored Study Demonstrates Benefits of Replacing Wheat Flour with Stabilized Rice Bran (SRB) in Battered and Fried Product Applications
11. Demand for NutraCea Rice Bran Oil Prompts Major Expansion of Irgovel Plant Ahead of Schedule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...r. Redlener Applauds Historic Effort but Points ou...Are Lost in Final Health Care Reform ,, NEW Y...ngland Journal of Medicine today published a Per...rm, co-authored by Irwin Redlener, M.D., president...nter for Disaster Preparedness and Professor of Cl...
(Date:12/4/2009)...irus will come back during winter isn,t known, CDC...ws) -- The number of states reporting widespread s...- to 25 from a high of 48 just two weeks ago, a U....e supply of H1N1 swine flu vaccine continues to in.... Centers for Disease Control and Prevention, said...
(Date:12/4/2009)...e inhaled through hookah, research shows , ...s are no safer than cigarettes for smoking tobacco...ple who smoke tobacco with a water pipe inhale car... for heart disease and nicotine addiction. , Th... smoked tobacco using a water pipe and a single ci...
(Date:12/4/2009)...they spurred blood vessel growth after heart attac... Adult stem cells appear to help repair heart atta...dy of 53 patients found that stem cells from donor...els in heart tissue damaged by heart attack. , ...hin 10 days of having a heart attack. During follo...
(Date:12/4/2009)...SON, Wis., Dec. 4 When t...isconsin Department of Health Services needed to g...an ever before. Join Sonic Foundry, Inc. (Nasdaq...edia webcasting and knowledge management, for a li...Department of Health Services, will share how in-h...
Breaking Medicine News(10 mins):Health News:New England Journal of Medicine Perspective by Irwin Redlener, MD, Addresses Health Care Reform 2Health News:Swine Flu Continues to Wane 2Health News:Water Pipes No Safer Than Cigarettes 2Health News:Live Webinar: Pandemic + Recession = Webcasting: Cost-Effective Streaming for Public Health Communications 2Health News:Live Webinar: Pandemic + Recession = Webcasting: Cost-Effective Streaming for Public Health Communications 3
...New technologies will drive US bone graft substitu...2, according to Millennium Research Group, WALTHA...herapeutics, Osteocel business, NuVasive has obtai...ther,innovative products will drive the BGS market...
...Finding may lead to improved pregnancy rates for i... , TUESDAY, May 13 (HealthDay News) -- Researc...ch embryos tabbed for in vitro fertilization (IVF)...uld also help fertility experts prevent accidental...
...No benefit seen for prehypertensive people in morn... May 14 (HealthDay News) -- A daily aspirin can co...bedtime, a Spanish study shows. , An aspirin taken...American Society of Hypertension annual meeting, i...
...HAE:TSX, MONTREAL, May 14 /PRNewswire-FirstCall/ ... it has obtained the consent required from its,sha...ategy designed to get,back into the clinic for the...he terms and conditions of 62.5 million,outstandin...
...BOULDER, Colo., May 14 Green tea consumption may,...k for cancer in addition,to supporting the medical...,study in the May/June 2008 issue of Alternative T...n cancers, 6 cancerous and 6 non-cancerous,adjacen...
...Agency is Appealing for Funds to Rebuild Schools a...http://www.opusa.org ), a Los Angeles-based intern...esponding with aid to the Sichuan Province in,cent... Chinese Army is taking the lead in immediate disa...
Other Medicine News:Health News:NuVasive Acquires First Stem Cell Bone Graft Substitute 2Health News:NuVasive Acquires First Stem Cell Bone Graft Substitute 3Health News:DNA Fingerprinting Could ID Viable Embryos 2Health News:Aspirin at Bedtime Lowers Blood Pressure 2Health News:Haemacure financing receives shareholder consent - Series B Warrants are amended 2Health News:Haemacure financing receives shareholder consent - Series B Warrants are amended 3Health News:Haemacure financing receives shareholder consent - Series B Warrants are amended 4Health News:Haemacure financing receives shareholder consent - Series B Warrants are amended 5Health News:Study Suggests Green Tea May Support the Medical Treatment of Stomach and Colon Cancer 2
(Date:12/4/2009)..., , BETHESDA, Md., Dec. 4 /PRNewswire-FirstC... the "Company") (OTC Bulletin Board: NWBO) announc...as allowed its patent application on a system for ...e of the Company,s DCVax® therapeutic cancer ...key to the very high concentration of dendritic ce...
(Date:12/3/2009)..., , ALISO VIEJO, Calif. and STATE COLLEGE...oftGenetics today announced the signing of an agre...services using SoftGenetics, NextGENe software for...Ambry. ,, (Logo: http://www.newscom.com/cgi...heidt PhD, Ambry,s CSO said, "Our team at Ambry ha...
(Date:12/3/2009)..., , WARRENDALE, Pa., Dec. 3 /PRNe...emonstrated PACS* injection-record integration cap...f North America in Chicago. The Connect.PACS(TM)...s capabilities of its kind, is the latest release ...matics Platform . ,, (Photo: http://www.new...
Breaking Medicine Technology:Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3Futronic Windows 7 Biometric Framework Driver is Signed by Microsoft 10364 1Futronic Windows 7 Biometric Framework Driver is Signed by Microsoft 10364 2The Urban Athlete and LivingFuel Partner to Offer 12 Week Healthy Weight Optimization Program 59504 1The Urban Athlete and LivingFuel Partner to Offer 12 Week Healthy Weight Optimization Program 59504 2The Urban Athlete and LivingFuel Partner to Offer 12 Week Healthy Weight Optimization Program 59504 3New Professional Network Brings Chinese Scientists and Researchers into International Community 59500 1New Professional Network Brings Chinese Scientists and Researchers into International Community 59500 2New Professional Network Brings Chinese Scientists and Researchers into International Community 59500 3New Professional Network Brings Chinese Scientists and Researchers into International Community 59500 4
...., Oct. 7 A study published in the,scientific jou...ewal,reported that InVitria,s ( http://www.InVitri...) was an effective replacement to bovine serum alb...The ground state of embryonic stem cell,self-renew...a recombinant,albumin in place of animal-derived s...
...Oct. 7 Taligen Therapeutics Inc.,today announced ...line,candidates were presented at the XXII Interna...The data highlighted the candidates, efficacy in,s...es., "These highlighted presentations, as well as...nce, reveal the deep expertise and expanding,knowl...
Other Medicine Technology:In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 2In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 4
Triglyceride (INT)
Alkaline phosphatase FS (IFCC)
Alkaline Phosphatase
Uric Acid (Uricase)
Medicine Products: